Search - tctmd.com

Displaying 201 - 220 of 301

Sort: Relevancy | Date

Presentation TCT 2015

Adventitial Injection Therapy for Restenosis: Rationale and Clinical Results to Date

Presenter: Prakash Krishnan, Mahmood K. Razavi, Christopher D. Owens

October 11, 2015

Presentation TCT 2015

Update on Bioresorbable Scaffolds for PAD

Presenter: Prakash Krishnan, Mahmood K. Razavi

October 11, 2015

Presentation TCT 2015

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Presenter: Gary M. Ansel, Michael R. Jaff

October 11, 2015

Presentation TCT 2015

Review and Perspectives of the Global Registry Data for Antiproliferative Therapies

Presenter: Gary M. Ansel, Michael R. Jaff, John R. Laird Jr

October 11, 2015

Presentation TCT 2015

Review of Multicenter, Randomized Outcomes Data of Antiproliferative Therapies: Zilver PTX, LEVANT II, In.PACT SFA, and DEFINITIVE AR

Presenter: Gary M. Ansel, Michael R. Jaff, Ravish Sachar

October 11, 2015

Presentation TCT 2015

Peering Through the Veil: Outcomes Reporting in SFA Intervention Decoded

Presenter: Gary M. Ansel, Michael R. Jaff, William A. Gray

October 11, 2015

Presentation TCT 2015

Everything You Wanted to Know About Endovascular Radiation Hazards but Were Afraid to Ask

Presenter: Gary M. Ansel, Michael R. Jaff, Lindsay S. Machan

October 11, 2015

Presentation TCT 2015

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Presenter: Gary M. Ansel, Michael R. Jaff, Ori Ben-Yehuda

October 11, 2015

Presentation TCT 2015

Is Peripheral Vascular Intervention Cost-effective? If So, From Whose Perspective?

Presenter: Gary M. Ansel, Michael R. Jaff

October 11, 2015

Presentation TCT 2015

Role of Atherectomy in Lower-Extremity Disease

Presenter: Julie Logan, Roger Gammon

October 11, 2015

Presentation TCT 2015

Why Is It So Complex? Simplifying Lower-Extremity Disease

Presenter: Julie Logan, Michael R. Jaff

October 11, 2015

News Industry News

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

October 06, 2015

News Daily News

观察性研究揭示了血管内和手术方案在治疗症状性 PAD 时的差异

L.A. McKeown

October 05, 2015

News Daily News

Un Estudio observacional Arroja Luz sobre las Opciones Endovascular y Quirúrgica para la EAP Sintomática

L.A. McKeown

October 05, 2015

News Daily News

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

L.A. McKeown

October 05, 2015

Presentation

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

Presenter: Thomas T. Tsai

October 02, 2015

Presentation Aortovascular 2015

Lower Extremity Superficial Venous Insufficiency: Etiology, prevalence and presentation

Presenter: Nicholas J. Morrissey

September 18, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year

L.A. McKeown

August 10, 2015

News Daily News

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

L.A. McKeown

August 05, 2015

Advertisement

Adventitial Injection Therapy for Restenosis: Rationale and Clinical Results to Date

Update on Bioresorbable Scaffolds for PAD

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Review and Perspectives of the Global Registry Data for Antiproliferative Therapies

Review of Multicenter, Randomized Outcomes Data of Antiproliferative Therapies: Zilver PTX, LEVANT II, In.PACT SFA, and DEFINITIVE AR

Peering Through the Veil: Outcomes Reporting in SFA Intervention Decoded

Everything You Wanted to Know About Endovascular Radiation Hazards but Were Afraid to Ask

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Is Peripheral Vascular Intervention Cost-effective? If So, From Whose Perspective?

Role of Atherectomy in Lower-Extremity Disease

Why Is It So Complex? Simplifying Lower-Extremity Disease

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

观察性研究揭示了血管内和手术方案在治疗症状性 PAD 时的差异

Un Estudio observacional Arroja Luz sobre las Opciones Endovascular y Quirúrgica para la EAP Sintomática

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

Lower Extremity Superficial Venous Insufficiency: Etiology, prevalence and presentation

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content